Logo image of EPRX

EUPRAXIA PHARMACEUTICALS INC (EPRX) Stock Analyst Ratings

USA - NASDAQ:EPRX - CA29842P1053 - Common Stock

5.68 USD
+0.19 (+3.46%)
Last: 10/23/2025, 8:00:02 PM
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to EPRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.06. This target is 41.91% above the current price.
EPRX was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about EPRX.
In the previous month the buy percentage consensus was at a similar level.
EPRX was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

EPRX Historical Analyst RatingsEPRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -29 -26 -23 -20 -17 -14 -11 -8 -5 -2 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 5.686.538.798.069.05 - 14.97% 54.81% 41.91% 59.36%

Related screens

EPRX Current Analyst RatingEPRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-08-20 HC Wainwright & Co. Reiterate Buy -> Buy
2025-07-24 Cantor Fitzgerald Initiate Overweight
2025-06-26 HC Wainwright & Co. Initiate Buy
2024-11-14 Rodman & Renshaw Initiate Buy